|
Demographics
|
|
Age (years)
|
30 (22–40)
|
30 (25–45)
|
27 (18–40)
|
0.104
|
|
Males (%)c
|
75 (70)
|
35 (78)
|
40 (65)
|
0.200
|
|
Fever prior to admission (days)
|
7 (6–9)
|
7 (6–8)
|
7 (6–9)
|
0.311
|
|
History of black or red urinec
|
20 (20)
|
5 (11)
|
15 (26)
|
0.100
|
|
Vomiting and diarrhea (days)
|
5 (1–6)
|
2.5 (1–5)
|
5 (3–9)
|
0.045
|
|
Comorbidities
|
|
Hypertensionc
|
5 (5)
|
2 (4)
|
3 (5)
|
1.000
|
|
Cardiovascular diseasec
|
6 (6)
|
2 (4)
|
4 (6)
|
1.000
|
|
Type 2 diabetesc
|
4 (4)
|
3 (7)
|
1 (2)
|
0.307
|
|
Enrolment clinical parameters
|
|
Glasgow Coma Score (max 15)
|
9 (8–14)
|
10 (9–14)
|
9 (7–14)
|
0.354
|
|
Systolic blood pressure (mmHg)
|
110 (100–120)
|
114 (102–120)
|
107 (99–120)
|
0.155
|
|
Mean arterial pressure (mmHg)
|
82 (72–90)
|
81 (74–89)
|
82 (71–94)
|
0.550
|
|
Pulse rate (breaths/min)
|
115 (96–132)
|
109 (93–131)
|
116 (97–132)
|
0.666
|
|
Respiratory rate (breaths/min)
|
34 (28–42)
|
32 (28–37)
|
36 (28–44)
|
0.370
|
|
Hemoglobinuria on enrolment# c
|
18 (17)
|
4 (9)
|
14 (24)
|
0.124
|
|
Number of severity criteria
|
2 (1–3)
|
1 (1–2)
|
2 (2–4)
|
<0.001
|
|
AKI stage at enrolment
|
|
Stage 1 (≥1.5 × baseline)c
|
16 (26)
|
--
|
16 (26)
|
--
|
|
Stage 2 (≥2.0–2.9 × baseline)c
|
16 (26)
|
--
|
16 (26)
|
--
|
|
Stage 3 (≥3.0 × baseline or ≥4 mg/dl)c
|
30 (48)
|
--
|
30 (48)
|
--
|
